Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
45.27
-0.30 (-0.66%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical
336.41M
Log In
Log In
Log In
Pharmaceutical Growth
88.07%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
274.17M
Log In
Log In
Log In
United States Growth
86.89%
Log In
Log In
Log In
Rest of the World
62.24M
Log In
Log In
Log In
Rest of the World Growth
93.43%
Log In
Log In
Log In